Global Alvimopan Market Size, Share, Trends and Forecast 2022-2030

Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting μ-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Industry Insights

Due to the COVID-19 pandemic, the global Alvimopan market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Alvimopan market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Alvimopan landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.

This report focuses on Alvimopan volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Alvimopan market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and India., etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Alvimopan market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Pharmaceutical Grade

Others

Segment by Application

Pharmaceutical

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck

Teva Pharmaceutical Industries Ltd

MSN Life Sciences Private Ltd

1 Alvimopan Market Overview
1.1 Product Overview and Scope of Alvimopan

1.2 Alvimopan Segment by Type

1.2.1 Global Alvimopan Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Pharmaceutical Grade

1.2.3 Others

1.3 Alvimopan Segment by Application

1.3.1 Global Alvimopan Sales Comparison by Application: (2022-2028)

1.3.2 Pharmaceutical

1.3.3 Other

1.4 Global Alvimopan Market Size Estimates and Forecasts

1.4.1 Global Alvimopan Revenue 2017-2028

1.4.2 Global Alvimopan Sales 2017-2028

1.4.3 Alvimopan Market Size by Region: 2017 Versus 2021 Versus 2028

2 Alvimopan Market Competition by Manufacturers

2.1 Global Alvimopan Sales Market Share by Manufacturers (2017-2022)

2.2 Global Alvimopan Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Alvimopan Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Alvimopan Manufacturing Sites, Area Served, Product Type

2.5 Alvimopan Market Competitive Situation and Trends

2.5.1 Alvimopan Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Alvimopan Players Market Share by Revenue

2.5.3 Global Alvimopan Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Alvimopan Retrospective Market Scenario by Region

3.1 Global Alvimopan Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Alvimopan Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Alvimopan Market Facts & Figures by Country

3.3.1 North America Alvimopan Sales by Country

3.3.2 North America Alvimopan Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Alvimopan Market Facts & Figures by Country

3.4.1 Europe Alvimopan Sales by Country

3.4.2 Europe Alvimopan Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Alvimopan Market Facts & Figures by Region

3.5.1 Asia Pacific Alvimopan Sales by Region

3.5.2 Asia Pacific Alvimopan Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Alvimopan Market Facts & Figures by Country

3.6.1 Latin America Alvimopan Sales by Country

3.6.2 Latin America Alvimopan Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Alvimopan Market Facts & Figures by Country

3.7.1 Middle East and Africa Alvimopan Sales by Country

3.7.2 Middle East and Africa Alvimopan Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Alvimopan Historic Market Analysis by Type

4.1 Global Alvimopan Sales Market Share by Type (2017-2022)

4.2 Global Alvimopan Revenue Market Share by Type (2017-2022)

4.3 Global Alvimopan Price by Type (2017-2022)

5 Global Alvimopan Historic Market Analysis by Application

5.1 Global Alvimopan Sales Market Share by Application (2017-2022)

5.2 Global Alvimopan Revenue Market Share by Application (2017-2022)

5.3 Global Alvimopan Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Alvimopan Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Merck Alvimopan Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Teva Pharmaceutical Industries Ltd

6.2.1 Teva Pharmaceutical Industries Ltd Corporation Information

6.2.2 Teva Pharmaceutical Industries Ltd Description and Business Overview

6.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolio

6.2.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates

6.3 MSN Life Sciences Private Ltd

6.3.1 MSN Life Sciences Private Ltd Corporation Information

6.3.2 MSN Life Sciences Private Ltd Description and Business Overview

6.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue and Gross Margin (2017-2022)

6.3.4 MSN Life Sciences Private Ltd Alvimopan Product Portfolio

6.3.5 MSN Life Sciences Private Ltd Recent Developments/Updates

7 Alvimopan Manufacturing Cost Analysis

7.1 Alvimopan Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Alvimopan

7.4 Alvimopan Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Alvimopan Distributors List

8.3 Alvimopan Customers

9 Alvimopan Market Dynamics

9.1 Alvimopan Industry Trends

9.2 Alvimopan Market Drivers

9.3 Alvimopan Market Challenges

9.4 Alvimopan Market Restraints

10 Global Market Forecast

10.1 Alvimopan Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Alvimopan by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Alvimopan by Type (2023-2028)

10.2 Alvimopan Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Alvimopan by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Alvimopan by Application (2023-2028)

10.3 Alvimopan Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Alvimopan by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Alvimopan by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer